Sunday, October 15, 2006
Peter Duesberg on AIDS
"The important thing is to not
stop questioning."
Albert Einstein
Peter H. Duesberg, Ph.D. is a professor of Molecular and Cell Biology at the University of California, Berkeley. Biographical Sketch
He isolated the first cancer gene through his work on retroviruses in 1970, and mapped the genetic structure of these viruses. This, and his subsequent work in the same field, resulted in his election to the National Academy of Sciences in 1986. He is also the recipient of a seven-year Outstanding Investigator Grant from the National Institutes of Health.
On the basis of his experience with retroviruses, Duesberg has challenged the virus-AIDS hypothesis in the pages of such journals as Cancer Research, Lancet, Proceedings of the National Academy of Sciences, Science, Nature, Journal of AIDS, AIDS Forschung, Biomedicine and Pharmacotherapeutics, New England Journal of Medicine and Research in Immunology. He has instead proposed the hypothesis that the various American/European AIDS diseases are brought on by the long-term consumption of recreational drugs and/or AZT itself, which is prescribed to prevent or treat AIDS. See The AIDS Dilemma: Drug diseases blamed on a passenger virus.
For a detailed discussion of American/European AIDS as opposed to African AIDS, see The African AIDS Epidemic: New and Contagious or Old Under a New Name.
Prof. Duesberg's findings have been a thorn in the side of the medical establishment and drug companies since 1987. Instead of engaging in scientific debate, however, the only response has been to cut-off funding to further test Professor's Duesberg's hypothesis.
*********************************************
I've just recently started seriously reading and considering what Dr. Peter Duesberg has to say on the subject of AIDS, as I am highly skeptical of what definitely appears to be an AIDS industry and know how highly toxic and EXPENSIVE the AIDS drugs are and how many guinea pigs they have at their disposal.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment